Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Viborg – page 4

50 clinical trials in Viborg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Viborg at a glance
50
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

50 trials in Viborg

Open in trial search

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Migraine

Not recruiting

Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine

Not recruiting

Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine

Not recruiting

Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Study Comparing Rituximab and Ocrelizumab for Patients with Active Multiple Sclerosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Rigshospitalet

Myocardial infarction

Not recruiting

Study on the Effects of Carvedilol, Metoprolol Tartrate, and Bisoprolol Fumarate in Patients After a Heart Attack with Normal Heart Pumping Function

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Frederiksberg Hospital

Study on Hydralazine, Isosorbide Dinitrate, and Metformin for Patients with Chronic Heart Failure and Reduced Heart Function

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Isosorbide Dinitrate

Type IIa hyperlipidaemia+1

Not recruiting

Study of Bempedoic Acid for Children Aged 6-17 with Familial Hypercholesterolemia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Bempedoic Acid
  • Sponsor:Esperion Therapeutics Inc.

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Lichen sclerosus

Not recruiting

Study on the Effectiveness and Safety of MC2-25 Cream for Women with Vulvar Lichen Sclerosus

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanyl Glutamine
  • Sponsor:Mc2 Therapeutics Limited

Dyslipidaemia

Not recruiting

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One
  • Sponsor:AstraZeneca AB

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Viborg

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focused on heart failure prevention and treatment of acute coronary syndromes. Studies evaluating novel therapies for reducing cardiovascular events and managing atherosclerotic disease.

  • Heart Failure Prevention
  • Myocardial Infarction Management
  • Atherosclerotic Disease Treatment

Multiple investigations exploring innovative approaches to prevent stroke and manage cardiovascular complications.

02 Nephrology Studies

Clinical research examining treatments for acute interstitial nephritis and evaluating new approaches for patients requiring hemodialysis care.

  • Kidney Disease Management
  • Hemodialysis Complications
  • Renal Treatment Protocols

Focus on improving outcomes for patients with various forms of kidney disease and related conditions.

03 Neurological Disorders

Advanced research into multiple sclerosis treatments and migraine management, including both preventive and acute therapeutic approaches.

  • Multiple Sclerosis Therapy
  • Migraine Prevention
  • Acute Headache Treatment

Innovative trials comparing established and novel treatments for neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.